MIRA INFORM REPORT

 

 

Report Date :

12.09.2012

 

IDENTIFICATION DETAILS

 

Name :

MIDAS PHARMA GMBH

 

 

Registered Office :

Rheinstr. 49, D 55218 Ingelheim

 

 

Country :

Germany

 

 

Date of Incorporation :

15.03.1988

 

 

Com. Reg. No.:

HRB 22154

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Wholesale of chemical products

 

 

No. of Employees :

28 employees

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

Payment Behaviour :

No Complaints

Litigation :

Clear

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31st, 2012

 

Country Name

Previous Rating

(31.12.2011)

Current Rating

(31.03.2012)

Germany

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

germany - ECONOMIC OVERVIEW

 

The German economy - the fifth largest economy in the world in PPP terms and Europe's largest - is a leading exporter of machinery, vehicles, chemicals, and household equipment and benefits from a highly skilled labor force. Like its Western European neighbors, Germany faces significant demographic challenges to sustained long-term growth. Low fertility rates and declining net immigration are increasing pressure on the country's social welfare system and necessitate structural reforms. Reforms launched by the government of Chancellor Gerhard SCHROEDER (1998-2005), deemed necessary to address chronically high unemployment and low average growth, contributed to strong growth in 2006 and 2007 and falling unemployment. These advances, as well as a government subsidized, reduced working hour scheme, help explain the relatively modest increase in unemployment during the 2008-09 recession - the deepest since World War II - and its decrease to 6.0% in 2011. GDP contracted 5.1% in 2009 but grew by 3.6% in 2010, and 2.7% in 2011. The recovery was attributable primarily to rebounding manufacturing orders and exports - increasingly outside the Euro Zone. Germany's central bank projects that GDP will grow 0.6% in 2012, a reflection of the worsening euro-zone financial crisis and the financial burden it places on Germany as well as falling demand for German exports. Domestic demand is therefore becoming a more significant driver of Germany's economic expansion. Stimulus and stabilization efforts initiated in 2008 and 2009 and tax cuts introduced in Chancellor Angela MERKEL's second term increased Germany's budget deficit to 3.3% in 2010, but slower spending and higher tax revenues reduce the deficit to 1.7% in 2011, below the EU's 3% limit. A constitutional amendment approved in 2009 limits the federal government to structural deficits of no more than 0.35% of GDP per annum as of 2016. Following the March 2011 Fukushima nuclear disaster, Chancellor Angela Merkel announced in May 2011 that eight of the country's 17 nuclear reactors would be shut down immediately and the remaining plants would close by 2022. Germany hopes to replace nuclear power with renewable energy. Before the shutdown of the eight reactors, Germany relied on nuclear power for 23% of its energy and 46% of its base-load electrical production.

 

Source : CIA

 

 

 

Company name

 

MIDAS Pharma GmbH

 

 

Company address

 

Rheinstr. 49

D 55218 Ingelheim

Telephone:        06132/990-0

Telefax:             06132/990-40

Homepage:        www.midas-pharma.com

E-mail:              info@midas-pharma.com

 

 

VAT no

 

DE148264856

 

 

CONCLUSION

 

Business relations are permissible.

 

 

Synthesis

 

LEGAL FORM               Private limited company

Date of foundation:         1988

Shareholders'

agreement:                    25.02.1988

Registered on:               15.03.1988

Commercial Register:     Local court 55116 Mainz

under:                           HRB 22154

Share capital:                 EUR             54,000.00

 

 

Shareholder

 

K. H. Schleicher

Vermögensverwaltungsgesellschaft mbH

Rheinstr. 49

D 55218 Ingelheim

Legal form: Private limited company

Share capital:     EUR             25,000.00

Share:             EUR             54,000.00

Registered on: 25.05.2001

Reg. data: 55116 Mainz, HRB 23169

 

 

Manager

 

Dirk Weidenbach

Oberer Zwerchweg 12

D 55218 Ingelheim

authorized to jointly represent the company

born: 25.09.1963

 

Manager:

                      Dr. Marcus Stumpf

                      D 55268 Nieder-Olm

                      authorized to jointly represent the company

                      born: 12.05.1969

 Manager:

                      Dr. Oliver Weyand

                      D 65033 Wiesbaden

                      authorized to jointly represent the company

                      born: 04.10.1971

 

 

Proxy

 

Michael Suess

D 55437 Ockenheim

authorized to jointly represent the company

born: 01.06.1961

 

Proxy:

                      Ulrich Baußmann

                      Virchowstr. 42

                      D 75015 Bretten

                      authorized to jointly represent the company

                      born: 22.01.1967

                      Profession: graduate engineer

                      Marital status: single

 Proxy:

                      Silvia Böhler

                      D 55218 Ingelheim

                      authorized to jointly represent the company

                      born: 04.01.1965

 Proxy:

                      Ellen Engel

                      D 63589 Linsengericht

                      authorized to jointly represent the company

                      born: 06.03.1961

                      née: Breckheimer

                      Marital status: unknown

 Proxy:

                      Dr. Peter Markus

                      D 51067 Köln

                      authorized to jointly represent the company

                      born: 10.04.1964

 Proxy:

                      Stefan Schröder

                      D 55218 Ingelheim

                      authorized to jointly represent the company

                      born: 20.04.1965

 Proxy:

                      Stefan Kaulen

                      D 55270 Essenheim

                      authorized to jointly represent the company

                      born: 22.01.1961

 

 

RESIGNED ACTING PERSONS AND SHAREHOLDERS

 

09.04.1997 - 12.04.2010  Manager

                          Karl Heinz Schleicher

                          D 55435 Gau-Algesheim

 

 

BUSINESS ACTIVITIES

 

Sectors

46750   Wholesale of chemical products

 

 

FINANCIAL INFORMATION

 

Payment experience:     within agreed terms

Negative information       :We have no negative information at hand.

 

REAL ESTATE

 

Type of ownership:         Tenant

Address                        Rheinstr. 49

D 55218 Ingelheim

 

Real Estate of:               Dr. Oliver Weyand

Type of ownership:         unknown

Address

D 65033 Wiesbaden

 

Land register documents were not available.

 

 

BANKERS

 

DEUTSCHE BANK, MAINZ A RHEIN

Sort. code: 55070040, BIC: DEUTDE5MXXX

 

SPARKASSE RHEIN-NAHE, GAU-ALGESHEIM

Sort. code: 56050180, BIC: MALADE51KRE

 

MAINZER VOLKSBANK ZW GAU-ALGESHEIM, GAU-ALGESHEIM

Sort. code: 55190000, BIC: MVBMDE55XXX

 

 

FINANCIAL FIGURES

 

 Financial year:      01.01. - 31.12.

 Turnover:            2010               EUR         65,400,000.00

 Share capital:                          EUR             54,000.00

 Equipment:                              EUR            250,000.00

 Ac/ts receivable:                       EUR          3,500,000.00

 Liabilities:                            EUR            300,000.00

 Total numbers of vehicles:                                     12

 Employees:                                                     28

 

The aforementioned business figures may partly be estimated information based on average values in the line of business.

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.55.52

UK Pound

1

Rs.88.85

Euro

1

Rs.70.85

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.